Episode 262: Strategies for Treating Wet Age-Related Macular Degeneration and more with Dr. Nancy Holekamp Straight From The Cutter's Mouth: A Retina Podcast
-
- Education
Dr. Nancy Holekamp joins the program to discuss her career development, the paradigm shift in terms of management of persistent subretinal fluid in wet age-related macular degeneration, strategies for improving AMD treatment including the port-delivery system and gene therapy, and her role in founding Women in Retina (WinR).
Financial Disclosures: Dr. Sridhar is a consultant for Alcon, Dorc, Oxurion, and Regeneron. Dr. Holekamp has received consulting fees from Allergan, Acucela, Apellis, Lineage Cell Therapeutics, Clearside Biosciences, Gemini, Genentech, Gyroscope, Katalyst Surgical, Nacuity, Notal Vision, Novartis, Polyactiva, and Regeneron. She is on the Speaker's Bureau for Allergan, Genentech, Novartis, Regeneron, and Spark. She performs contracted research with Genentech, Gemini, and Gyroscope and holds an intellectual property patent with Katalyst Surgical.
Dr. Nancy Holekamp joins the program to discuss her career development, the paradigm shift in terms of management of persistent subretinal fluid in wet age-related macular degeneration, strategies for improving AMD treatment including the port-delivery system and gene therapy, and her role in founding Women in Retina (WinR).
Financial Disclosures: Dr. Sridhar is a consultant for Alcon, Dorc, Oxurion, and Regeneron. Dr. Holekamp has received consulting fees from Allergan, Acucela, Apellis, Lineage Cell Therapeutics, Clearside Biosciences, Gemini, Genentech, Gyroscope, Katalyst Surgical, Nacuity, Notal Vision, Novartis, Polyactiva, and Regeneron. She is on the Speaker's Bureau for Allergan, Genentech, Novartis, Regeneron, and Spark. She performs contracted research with Genentech, Gemini, and Gyroscope and holds an intellectual property patent with Katalyst Surgical.